Skip to content

Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age.

Demographic, Clinical, Dermoscopic, Phenotypic and Genetic Characteristics of Adult Patients With Melanoma Diagnosis <40 Years Age. A Prospective, Monocentric Observational Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06994208
Acronym
MELA_2025
Enrollment
25
Registered
2025-05-29
Start date
2025-12-02
Completion date
2028-08-31
Last updated
2025-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Melanoma of Skin

Brief summary

The primary objective of the study is to analyse a local cohort of patients aged 18-39 years with melanoma diagnosis in order to determine the prevalence of the disease in this age group. Secondary objectives are the following: * To identify risk factors associated with melanoma in young people. * To characterise the phenotype and dermoscopic features of melanoma in patients aged 18-39 years. * To analyse the relationship between the clinical and histopathological features of melanoma in young people. * To identify the mutational status of B-RAF in the sample of patients analysed.

Interventions

None listed

Sponsors

Ente Ospedaliero Ospedali Galliera
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 39 Years
Healthy volunteers
No

Inclusion criteria

1. written informed consent 2. age \> 18 years and \< 40 years 3. diagnosis of cutaneous melanoma even non-primary

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Melanoma prevalence3 yearsEstimated prevalence of melanoma in a cohort group of patients aged 18 - 39 years

Secondary

MeasureTime frameDescription
Risk factor3 yearsIdentification of risk factors associated with melanoma in young people.
Melanoma phenotype3 yearsDescription of the main phenotypic of melanoma in this age group.
Histopathological feature3 yearsEvaluation of the likely association between clinical and histopathological features of melanoma in young people.
Mutational status3 yearsIdentification of the presence of B-RAF mutations
Dermoscopy of melanoma3 yearsDescription of the main dermoscopic characteristics of melanoma in this age group.

Countries

Italy

Contacts

Primary ContactSanja Javor, MD
sanja.javor@galliera.it+390105634271
Backup ContactDavide Corradengo
davide.corradengo@galliera.it+39010.563.4580

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026